ReviewTherapeutic advances in medical oncology2023

Novel systemic therapies in the management of tyrosine kinase inhibitor-pretreated patients with epidermal growth factor receptor-mutant non-small-cell lung cancer.

Yang-Si Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.